Your browser doesn't support javascript.
loading
Verifying a novel bile cytology scoring system.
Hayakawa, Chie; Hoshikawa, Masahiro; Imura, Johji; Ueno, Takahiko; Koike, Junki.
Afiliación
  • Hayakawa C; Department of Diagnostic Pathology, Kawasaki Municipal Tama Hospital, Kawasaki, Kanagawa, Japan.
  • Hoshikawa M; Department of Diagnostic Pathology, Machida Municipal Hospital, Tokyo, Japan.
  • Imura J; Department of Diagnostic Pathology, Kumagaya General Hospital, Saitama, Japan.
  • Ueno T; Unit of Medical Informatics, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Koike J; Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Diagn Cytopathol ; 52(9): 485-498, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38785342
ABSTRACT

BACKGROUND:

The scoring system for bile cytology (SSBC) aims to improve bile cytology diagnostic accuracy. Here, the practicality of SSBC was verified by multiple cytotechnologists.

METHODS:

Bile cytological specimens were evaluated by 24 cytotechnologists using SSBC. The samples were assessed before using the SSBC (first-time assessment) according to three categories benign, indeterminate, and malignant. A first scoring evaluation (FSE) was then performed using SSBC; each item in the scoring system was classified as present or absent. After distributing an instruction sheet with diagnostic criteria, a second scoring evaluation (SSE) was performed using SSBC. Each method was evaluated using diagnostic accuracy and interobserver and intraobserver agreement.

RESULTS:

Several samples were assessed as indeterminate in the first-time assessment. Although the specificity of the SSE improved, the sensitivity and accuracy decreased compared with those of the FSE. The overall interobserver agreement was fair for all parameters, including abnormal chromatin, irregular internuclear distances, irregularly overlapped nuclei, irregular cluster margins, and final evaluation in the FSE and SSE. The final evaluation by histological type exhibited slight agreement for well-differentiated tubular adenocarcinoma and almost perfect agreement for poorly differentiated tubular adenocarcinoma in the FSE and SSE. For moderately differentiated tubular adenocarcinoma, agreement was moderate in the FSE and fair in the SSE. For cholangitis, a slight agreement was observed in the FSE, which improved to fair in the SSE.

CONCLUSIONS:

Although the SSBC is expected to improve specificity, there exists ambiguity regarding SSBC criteria and interindividual assessment differences. Therefore, the objective assessment method should be revised.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bilis / Citodiagnóstico Límite: Humans Idioma: En Revista: Diagn Cytopathol Asunto de la revista: PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bilis / Citodiagnóstico Límite: Humans Idioma: En Revista: Diagn Cytopathol Asunto de la revista: PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos